¿Qué es el sitio web?

https://www.facebook.com/110210698432219/

CorrGene Biotech

Name: CorrGene Biotech
Address: Scientific Park of MadridCalle Faraday, 7 Campus de Cantoblanco, Madrid, 28048, ES
Telephone: +8618126205197

Casa
España
Madrid
CorrGene Biotech

An innovative biotech company that focuses on the research and development of new drugs for cancer and rare diseases using gene editing and stem cell therapy.

18/10/2022

Tests for Pyruvate Kinase Deficiency：
Enzyme Activity Test & Genetic Testing

13/10/2022

Management of pyruvate kinase deficiency in children and adults

13/10/2022

Blood smear from a patient with pyruvate kinase deficiency. Notable for echinocytes, polychromasia, and nRBCs. What is one way this patient was treated?

08/10/2022

Congratulations to this year’s Nobel Prize winners in Chemistry, Physics and Physiology or Medicine. Many of these scientists have been chairs and speakers at GRC’s. We are honored to have these prestigious individuals as part of our community!

21/09/2022

How will Pyruvate kinase (PK) deficiency affect adults or children?

21/09/2022

Pyruvate kinase (PK) deficiency is a rare genetic disease that affects red blood cells. Everyone who has PK deficiency is born with it, even if they are diagnosed later in life. To understand how PK deficiency affects you, you need an understanding of the role .

21/09/2022

What does pyruvate kinase do？
1.Pyruvate kinase deficiency is a rare genetic disease that
causes red blood cells to break apart easily (hemolysis).
2.Some patients have no or few symptoms; others have
severe hemolytic anemia (a low red blood cell count or
low hemoglobin level) that needs treatment with regular
red blood cell transfusions.
3.Hemolytic anemia is associated with complications that
need monitoring, including the development of gallstones,
iron overload and low bone density.
4.Common supportive treatments for pyruvate kinase
deficiency include blood transfusions, removal of the
spleen (splenectomy) and medications to remove excess
iron from the blood (chelation therapy).
5.Research into new treatments for pyruvate kinase
deficiency is very promising.

21/09/2022

CorrGene: Patented technology to cure Pyruvate Kinase Deficiency
Inventors: Segovia, Jose-Carlos; Fañanas-Baquero, Sara; Quintana-Bustamante, Oscar; Porteus, Matthew
Institution: CIEMAT-CIBERER / IIS-FJD and Stanford University
Patent name: Pyruvate kinase deficiency (PKD) gene editing treatment method
International Patent No.PCT/EP2021/067719

21/09/2022

CorrGene:In March 2022, the CG001 pipeline of Pyruvate Kinase Deficiency obtained the European Medicines Agency (EMA) orphan drug status, discussed with the European Medicines Agency and successfully passed the pre-IND meeting, which will be synchronized in Europe and the United States in June 2023 clinical application
https://ec.europa.eu/health/documents/community-register/html/o2580.htm

20/07/2022

CorrGene Biotech Laboratory in Madrid, Spain

Dirección

Scientific Park Of MadridCalle Faraday, 7 Campus De Cantoblanco
Madrid
28048

Teléfono

+8618126205197

Página web

facebook.com

Notificaciones

Sé el primero en enterarse y déjanos enviarle un correo electrónico cuando CorrGene Biotech publique noticias y promociones. Su dirección de correo electrónico no se utilizará para ningún otro fin, y puede darse de baja en cualquier momento.